Rigel Pharmaceuticals Inc (RIGL)

Rigel Pharmaceuticals Inc (RIGL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $881M; returns 1 day -1.5%, 1 week +4.7%, 1 year +63.8%.

Rigel Pharmaceuticals is a commercial-stage biotechnology company specialized in small-molecule therapies for hematologic disorders and cancer.

Groups RIGL belongs to

• Biotechnology
• Commercial Stage Biotech
• Healthcare
• Pharmaceuticals
• Oncology
• Hematology
• Cancer Therapeutics
• Hematologic Malignancies
• Life Sciences
• Commercial Stage

RIGL financial model: income statement, cash flow and balance sheet